From Genetics to Genomics: Facing the Liability Implications in Clinical Care

for the LawSeq Liability Task Force

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Abstract

Health care is transitioning from genetics to genomics, in which single-gene testing for diagnosis is being replaced by multi-gene panels, genome-wide sequencing, and other multi-genic tests for disease diagnosis, prediction, prognosis, and treatment. This health care transition is spurring a new set of increased or novel liability risks for health care providers and test laboratories. This article describes this transition in both medical care and liability, and addresses 11 areas of potential increased or novel liability risk, offering recommendations to both health care and legal actors to address and manage those liability risks.

Original languageEnglish (US)
Pages (from-to)11-43
Number of pages33
JournalJournal of Law, Medicine and Ethics
Volume48
Issue number1
DOIs
StatePublished - Mar 1 2020

Bibliographical note

Publisher Copyright:
© 2020 American Society of Law, Medicine & Ethics.

Fingerprint

Dive into the research topics of 'From Genetics to Genomics: Facing the Liability Implications in Clinical Care'. Together they form a unique fingerprint.

Cite this